Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?
- PMID: 21606532
- DOI: 10.1093/infdis/jir187
Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?
Abstract
Background: It is unclear whether pandemic 2009 influenza A (pH1N1) infection caused more significant disease among hospitalized adults than seasonal influenza.
Methods: A prospective, observational study was conducted in adults hospitalized with polymerase chain reaction-confirmed pH1N1 infection in 2 acute-care general hospitals from June 2009 to May 2010 (n = 382). Complications and outcomes were described and compared with those in a seasonal influenza cohort (2007-2008, same hospitals; n = 754).
Results: Hospitalized patients with pH1N1 influenza were younger than those with seasonal influenza (mean age ± standard deviation, 47 ± 20 vs 70 ± 19 years) and fewer had comorbid conditions (48% vs 64%). The rate of positive immunofluorescence assay results was low (54% vs 84%), and antiviral use was frequent (96% vs 52%). Most patients in both cohorts developed complicated illnesses (67.8% vs 77.1%), but patients with pH1N1 influenza had higher rates of extrapulmonary complications (23% vs 16%; P = .004) and intensive care unit admission and/or death (patient age <35 years, 2.3% vs 0%; 35-65 years, 12.4% vs 3.2%; >65 years, 13.5% vs 8.5%; adjusted odds ratio [OR] 2.13; 95% confidence interval [CI], 1.25-3.62; P = .005). Patients who received antiviral treatment within 96 h after onset had better survival (log-rank test, P < .001). However, without timely treatment, the mortality risk was higher with pH1N1 infection (9.0% vs 5.8% for seasonal influenza; adjusted OR, 6.85; 95% CI, 1.64-28.65; P = .008]. Bacterial superinfection worsened outcomes.
Conclusions: Adults hospitalized for pH1N1 influenza had significant complications and mortality despite being younger than patients with seasonal influenza. Antiviral treatment within 96 h may improve survival.
Similar articles
-
HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1)--United States, spring and summer 2009.Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S183-8. doi: 10.1093/cid/ciq036. Clin Infect Dis. 2011. PMID: 21342893
-
Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009.Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S50-9. doi: 10.1093/cid/ciq021. Clin Infect Dis. 2011. PMID: 21342900
-
Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases.Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S38-45. doi: 10.1016/j.ajog.2011.02.037. Epub 2011 Apr 20. Am J Obstet Gynecol. 2011. PMID: 21507375
-
Complications of seasonal and pandemic influenza.Crit Care Med. 2010 Apr;38(4 Suppl):e91-7. doi: 10.1097/CCM.0b013e3181c92eeb. Crit Care Med. 2010. PMID: 19935413 Review.
-
Diagnosis, management and outcomes of adults hospitalized with influenza.Antivir Ther. 2012;17(1 Pt B):143-57. doi: 10.3851/IMP2059. Epub 2012 Feb 3. Antivir Ther. 2012. PMID: 22311561 Review.
Cited by
-
Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.J Infect. 2013 Sep;67(3):185-93. doi: 10.1016/j.jinf.2013.05.006. Epub 2013 Jun 6. J Infect. 2013. PMID: 23747416 Free PMC article.
-
Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.BMC Public Health. 2016 Aug 22;16 Suppl 1(Suppl 1):757. doi: 10.1186/s12889-016-3378-1. BMC Public Health. 2016. PMID: 27556802 Free PMC article.
-
Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection.Intensive Care Med. 2012 Jul;38(7):1152-61. doi: 10.1007/s00134-012-2565-5. Epub 2012 Apr 18. Intensive Care Med. 2012. PMID: 22527080
-
Adjunctive therapies and immunomodulatory agents in the management of severe influenza.Antiviral Res. 2013 Jun;98(3):410-6. doi: 10.1016/j.antiviral.2013.03.019. Epub 2013 Apr 8. Antiviral Res. 2013. PMID: 23578727 Free PMC article. Review.
-
Interleukin-17-A multifaceted cytokine in viral infections.J Cell Physiol. 2021 Dec;236(12):8000-8019. doi: 10.1002/jcp.30471. Epub 2021 Jun 16. J Cell Physiol. 2021. PMID: 34133758 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical